Aakaar Medical Technologies Limited

Aakaar Medical Technologies Limited (AAKAAR) is a micro-cap Fast Moving Consumer Goods company valued at ₹101 crore operating in Personal Care on the NSE and BSE.

Recent price move

Aakaar Medical Technologies Limited last traded at ₹71, modestly up 0.07% on the day.

Recent developments

On 2026-03-31, the company reported its latest quarter results, showing revenue of ₹42 crore and net profit of ₹7 crore, up 22.9% and 33.2% from the same quarter a year earlier. The company has shown strong growth over the past five years, with profit growing at 65.2% annually and revenue increasing at 40.0% annually.

Financial performance

The company's business is improving, with annual revenue rising 8.7% and annual net profit increasing 10.1%. The latest quarter saw revenue rise 22.9% and net profit jump 33.2% compared to the same quarter a year earlier. Margins have slightly improved, with the net profit margin rising 0.1 percentage points to 9.9%, while return on equity and return on capital employed remain stable at 12.2% and 15.0%, respectively.

Valuation multiples

The stock trades at 14.2 times earnings, a discount to the Fast Moving Consumer Goods median of 19.6, 1.64 times book value.

Things to watch

The company's stock is 27.8% below its 52-week high, and it has not paid out any dividends despite reporting repeated profits. The company's latest quarter results show a net profit of ₹7 crore, but this is not consistent with the previous quarter, which reported a net loss of ₹1 crore.

Where it stands

The company has shown strong revenue and profit growth over the past five years, with profit growing at 65.2% annually and revenue increasing at 40.0% annually. The latest quarter saw net profit rise 33.2% compared to the same quarter a year earlier, but the company has not paid out any dividends.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.